https://www.aferetica.com/en/pertransplantation/haemoadsorption-reduces-the-inflammatory-response-and-improves-blood-flow-during-ex-vivo-renal-perfusion-in-an-experimental-model-en/ 2022-09-26T07:48:15+00:00 https://www.aferetica.com/en/pertransplantation/cytokine-absorption-during-human-kidney-perfusion-reduces-delayed-graft-function-associated-inflammatory-gene-signature-en/ 2022-09-26T08:21:18+00:00 https://www.aferetica.com/en/pertransplantation/perfusate-adsorption-during-ex-vivo-lung-perfusion-improves-early-post-transplant-lung-function-en/ 2022-09-26T08:25:57+00:00 https://www.aferetica.com/en/pertransplantation/a-new-ex-situ-machine-perfusion-device-a-preliminary-evaluation-using-a-model-of-donors-after-circulatory-death-pig-livers-en/ 2022-09-26T08:29:38+00:00 https://www.aferetica.com/en/pertransplantation/cytokine-adsorber-use-during-dcd-heart-perfusion-counteracts-coronary-microvascular-dysfunction-2/ 2023-03-13T07:02:56+00:00 https://www.aferetica.com/pertransplantation/use-of-cytosorb-in-a-patient-with-ischemia-reperfusion-injury-hemorrhagic-shock-and-hyperbilirubinemia-following-liver-transplantation/ 2023-03-13T07:08:28+00:00 https://www.aferetica.com/en/pertransplantation/use-of-cytosorb-in-a-patient-with-ischemia-reperfusion-injury-hemorrhagic-shock-and-hyperbilirubinemia-following-liver-transplantation-2/ 2023-03-13T07:11:20+00:00 https://www.aferetica.com/pertransplantation/hemoadsorption-in-the-critically-ill-final-results-of-the-international-cytosorb-registry/ 2023-03-13T07:16:18+00:00 https://www.aferetica.com/en/pertransplantation/hemoadsorption-in-the-critically-ill-final-results-of-the-international-cytosorb-registry-2/ 2023-03-13T07:21:37+00:00 https://www.aferetica.com/en/pertransplantation/reduction-of-primary-graft-dysfunction-using-cytokine-adsorption-during-organ-preservation-and-after-lung-transplantation-2/ 2023-03-13T07:29:59+00:00 https://www.aferetica.com/pertransplantation/use-of-the-cytosorb-filter-for-elimination-of-residual-therapeutic-argatroban-concentrations-during-heparinized-cardiopulmonary-bypass-for-heart-transplantation/ 2023-03-13T07:33:50+00:00 https://www.aferetica.com/en/pertransplantation/use-of-the-cytosorb-filter-for-elimination-of-residual-therapeutic-argatroban-concentrations-during-heparinized-cardiopulmonary-bypass-for-heart-transplantation-2/ 2023-03-13T07:35:48+00:00 https://www.aferetica.com/pertransplantation/cytokine-mass-balance-levels-in-donation-after-circulatory-death-donors-using-hemoadsorption-case-series-report/ 2023-03-13T07:55:44+00:00 https://www.aferetica.com/en/pertransplantation/cytokine-mass-balance-levels-in-donation-after-circulatory-death-donors-using-hemoadsorption-case-series-report-2/ 2023-03-13T07:58:25+00:00 https://www.aferetica.com/pertransplantation/first-experience-with-extracorporeal-cytokine-adsorption-therapy-after-lung-transplantation/ 2023-03-13T08:03:43+00:00 https://www.aferetica.com/en/pertransplantation/first-experience-with-extracorporeal-cytokine-adsorption-therapy-after-lung-transplantation-2/ 2023-03-13T08:05:10+00:00 https://www.aferetica.com/pertransplantation/can-the-cytokine-adsorber-cytosorb-help-to-mitigate-cytokine-storm-and-reduce-mortality-in-critically-ill-patients-a-propensity-score-matching-analysis/ 2023-03-13T09:27:11+00:00 https://www.aferetica.com/en/pertransplantation/can-the-cytokine-adsorber-cytosorb-help-to-mitigate-cytokine-storm-and-reduce-mortality-in-critically-ill-patients-a-propensity-score-matching-analysis-2/ 2023-03-13T09:28:36+00:00 https://www.aferetica.com/pertransplantation/opportunities-controversies-and-challenges-of-extracorporeal-hemoadsorption-with-cytosorbr-during-ecmo/ 2023-03-13T09:32:32+00:00 https://www.aferetica.com/en/pertransplantation/opportunities-controversies-and-challenges-of-extracorporeal-hemoadsorption-with-cytosorbr-during-ecmo-2/ 2023-03-13T09:34:22+00:00 https://www.aferetica.com/pertransplantation/successful-elimination-of-bilirubin-in-critically-ill-patients-with-acute-liver-dysfunction-using-a-cytokine-adsorber-and-albumin-dialysis-a-pilot-study/ 2023-03-13T10:06:58+00:00 https://www.aferetica.com/en/pertransplantation/successful-elimination-of-bilirubin-in-critically-ill-patients-with-acute-liver-dysfunction-using-a-cytokine-adsorber-and-albumin-dialysis-a-pilot-study-2/ 2023-03-13T10:08:38+00:00 https://www.aferetica.com/pertransplantation/impact-of-cytosorb-on-kinetics-of-vancomycin-and-bivalirudin-in-critically-ill-patients/ 2023-03-13T10:11:11+00:00 https://www.aferetica.com/en/pertransplantation/impact-of-cytosorb-on-kinetics-of-vancomycin-and-bivalirudin-in-critically-ill-patients-2/ 2023-03-13T10:13:12+00:00 https://www.aferetica.com/pertransplantation/novel-diagnostic-and-therapeutic-techniques-reveal-changed-metabolic-profiles-in-recurrent-focal-segmental-glomerulosclerosis/ 2023-03-13T10:28:54+00:00 https://www.aferetica.com/en/pertransplantation/novel-diagnostic-and-therapeutic-techniques-reveal-changed-metabolic-profiles-in-recurrent-focal-segmental-glomerulosclerosis-2/ 2023-03-13T10:30:18+00:00 https://www.aferetica.com/pertransplantation/case-report-successful-use-of-extracorporeal-therapies-after-ecmo-resuscitation-in-a-pediatric-kidney-transplant-recipient/ 2023-03-13T10:32:06+00:00 https://www.aferetica.com/en/pertransplantation/case-report-successful-use-of-extracorporeal-therapies-after-ecmo-resuscitation-in-a-pediatric-kidney-transplant-recipient-2/ 2023-03-13T10:33:05+00:00 https://www.aferetica.com/pertransplantation/experience-of-using-an-extracorporeal-cytokine-hemoadsorber-cytosorb-in-systemic-inflammatory-response-syndrome-after-heart-transplantation/ 2023-03-13T10:34:47+00:00 https://www.aferetica.com/en/pertransplantation/experience-of-using-an-extracorporeal-cytokine-hemoadsorber-cytosorb-in-systemic-inflammatory-response-syndrome-after-heart-transplantation-2/ 2023-03-13T10:36:07+00:00 https://www.aferetica.com/pertransplantation/sars-cov-2-infection-in-kidney-transplant-recipients-experience-of-the-italian-marche-region/ 2023-03-13T10:38:04+00:00 https://www.aferetica.com/en/pertransplantation/sars-cov-2-infection-in-kidney-transplant-recipients-experience-of-the-italian-marche-region-2/ 2023-03-13T10:39:28+00:00 https://www.aferetica.com/pertransplantation/first-experiences-of-hemoadsorption-in-the-donation-after-circulatory-death/ 2023-03-13T10:41:57+00:00 https://www.aferetica.com/en/pertransplantation/first-experiences-of-hemoadsorption-in-the-donation-after-circulatory-death-2/ 2023-03-13T10:43:21+00:00 https://www.aferetica.com/en/pertransplantation/the-challenges-of-o2-detection-in-biological-fluids-classical-methods-and-translation-to-clinical-applications-2/ 2023-03-29T12:50:55+00:00 https://www.aferetica.com/en/pertransplantation/cytokines-removal-during-ex-vivo-lung-perfusion-initial-clinical-experience-2/ 2023-09-15T13:28:36+00:00 https://www.aferetica.com/pertransplantation/use-of-intraoperative-haemoadsorption-in-patients-undergoing-heart-transplantation/ 2024-03-13T10:34:55+00:00 https://www.aferetica.com/en/pertransplantation/use-of-intraoperative-haemoadsorption-in-patients-undergoing-heart-transplantation-a-proof-of-concept-randomized-trial/ 2024-03-13T10:44:54+00:00 https://www.aferetica.com/pertransplantation/a-new-ex-situ-machine-perfusion-device-a-preliminary-evaluation-using-a-model-of-donors-after-circulatory-death-pig-livers/ 2024-04-10T14:36:50+00:00 https://www.aferetica.com/pertransplantation/cytokine-absorption-during-human-kidney-perfusion-reduces-delayed-graft-function-associated-inflammatory-gene-signature/ 2024-04-10T15:19:02+00:00 https://www.aferetica.com/pertransplantation/cytokine-adsorber-use-during-dcd-heart-perfusion-counteracts-coronary-microvascular-dysfunction/ 2024-04-10T15:19:36+00:00 https://www.aferetica.com/pertransplantation/haemoadsorption-reduces-the-inflammatory-response-and-improves-blood-flow-during-ex-vivo-renal-perfusion-in-an-experimental-model/ 2024-04-10T15:20:18+00:00 https://www.aferetica.com/pertransplantation/the-challenges-of-o2-detection-in-biological-fluids-classical-methods-and-translation-to-clinical-applications/ 2024-04-10T15:20:54+00:00 https://www.aferetica.com/pertransplantation/cytokines-removal-during-ex-vivo-lung-perfusion-initial-clinical-experience/ 2024-04-10T15:22:38+00:00 https://www.aferetica.com/pertransplantation/perfusate-adsorption-during-ex-vivo-lung-perfusion-improves-early-post-transplant-lung-function/ 2024-04-10T15:23:08+00:00 https://www.aferetica.com/pertransplantation/reduction-of-primary-graft-dysfunction-using-cytokine-adsorption-during-organ-preservation-and-after-lung-transplantation/ 2024-04-10T15:23:40+00:00 https://www.aferetica.com/pertransplantation/hemoadsorption-in-organ-preservation-and-transplantation-a-narrative-review/ 2024-05-09T06:31:48+00:00 https://www.aferetica.com/en/pertransplantation/hemoadsorption-in-organ-preservation-and-transplantation-a-narrative-review-en/ 2024-05-09T06:39:21+00:00 https://www.aferetica.com/en/pertransplantation/proof-of-concept-of-a-new-option-to-preserve-and-evaluate-kidney-grafts-from-cadaveric-donors-en-bloc-dual-kidney-specimen-hypothermic-oxygenated-machine-perfusion-model-from-an-animal-dcd-2/ 2024-07-18T07:03:39+00:00 https://www.aferetica.com/en/pertransplantation/preliminary-experience-with-perlife-system-for-ex-situ-liver-perfusion-and-purification-2/ 2024-08-26T15:37:33+00:00 https://www.aferetica.com/pertransplantation/successful-kidney-transplantation-despite-therapeutic-anticoagulation-effective-apixaban-elimination-by-hemoadsorption/ 2024-11-27T14:16:42+00:00 https://www.aferetica.com/en/pertransplantation/successful-kidney-transplantation-despite-therapeutic-anticoagulation-effective-apixaban-elimination-by-hemoadsorption-en/ 2024-11-27T14:23:02+00:00 https://www.aferetica.com/pertransplantation/orthostatic-ex-vivo-lung-perfusion-evlp-a-proof-of-concept/ 2025-02-04T07:46:06+00:00 https://www.aferetica.com/en/pertransplantation/orthostatic-ex-vivo-lung-perfusion-evlp-a-proof-of-concept-2/ 2025-02-04T07:46:43+00:00 https://www.aferetica.com/pertransplantation/preliminary-experience-with-perlife-system-for-ex-situ-liver-perfusion-and-purification/ 2025-02-04T07:47:17+00:00 https://www.aferetica.com/pertransplantation/proof-of-concept-of-a-new-option-to-preserve-and-evaluate-kidney-grafts-from-cadaveric-donors-en-bloc-dual-kidney-specimen-hypothermic-oxygenated-machine-perfusion-model-from-an-animal-dcd/ 2025-02-04T07:48:05+00:00 https://www.aferetica.com/en/pertransplantation/normothermic-machine-perfusion-and-inflammatory-mediators-adsorption-first-kidney-transplant-experience-en/ 2025-09-08T10:31:20+00:00 https://www.aferetica.com/pertransplantation/normothermic-machine-perfusion-and-inflammatory-mediators-adsorption-first-kidney-transplant-experience/ 2025-09-08T10:32:17+00:00 https://www.aferetica.com/pertransplantation/enhanced-donor-lung-viability-during-prolonged-ex-vivo-lung-perfusion-using-ecmo-technology/ 2025-11-19T07:51:48+00:00 https://www.aferetica.com/en/pertransplantation/enhanced-donor-lung-viability-during-prolonged-ex-vivo-lung-perfusion-using-ecmo-technology-2/ 2025-11-19T07:56:31+00:00 https://www.aferetica.com/pertransplantation/first-use-of-a-novel-system-for-allograft-preservation-in-a-dcd-donation-after-cardiac-death-heart-transplantation/ 2025-12-19T15:59:28+00:00 https://www.aferetica.com/en/pertransplantation/first-use-of-a-novel-system-for-allograft-preservation-in-a-dcd-donation-after-cardiac-death-heart-transplantation-en/ 2025-12-19T16:09:43+00:00 https://www.aferetica.com/pertransplantation/adsorbimento-delle-citochine-durante-la-perfusione-ex-situ-di-fegati-da-donatori-anziani-uno-studio-pilota-prospettico-e-randomizzato/ 2026-01-29T14:42:29+00:00 https://www.aferetica.com/en/pertransplantation/cytokines-adsorption-during-ex-situ-machine-perfusion-of-liver-grafts-from-elderly-donors-a-pilot-prospective-randomized-study/ 2026-01-29T15:06:39+00:00 https://www.aferetica.com/pertransplantation/acute-kidney-injury-post-liver-transplant-using-grafts-treated-with-hypothermic-machine-perfusion-from-biology-to-surgical-aspects/ 2026-04-16T13:27:56+00:00 https://www.aferetica.com/en/pertransplantation/acute-kidney-injury-post-liver-transplant-using-grafts-treated-with-hypothermic-machine-perfusion-from-biology-to-surgical-aspects-en/ 2026-04-16T13:31:26+00:00 https://www.aferetica.com/pertransplantation/integration-of-in-situ-split-procurement-and-ex-situ-hyper-reduction-under-dual-hypothermic-oxygenated-perfusion-for-neonatal-liver-transplantation/ 2026-04-20T06:42:07+00:00 https://www.aferetica.com/en/pertransplantation/integration-of-in-situ-split-procurement-and-ex-situ-hyper-reduction-under-dual-hypothermic-oxygenated-perfusion-for-neonatal-liver-transplantation-en/ 2026-04-20T06:45:17+00:00